HRCT CHEST

An HRCT CHEST, or High-Resolution Computed Tomography of the Chest, is a specialized CT examination designed to produce highly detailed images of the lung tissue and airways. It uses thin image sections and high-spatial-resolution reconstruction techniques to show fine structural changes that may not be visible clearly on a routine chest X-ray or standard CT reconstruction.

HRCT is particularly useful for assessing diseases that affect the lung parenchyma, which includes the air sacs, supporting interstitial tissues and small airways. It may help identify the pattern, distribution and extent of interstitial lung disease, pulmonary fibrosis, bronchiectasis, emphysema, occupational lung disease and other diffuse pulmonary abnormalities.

A routine HRCT Chest is generally performed without intravenous contrast material because the primary purpose is to examine the fine internal structure of the lungs. Depending on the clinical indication, additional images may be acquired while the patient breathes out, lies in a prone position or follows another specific breathing instruction. These additional views can help distinguish true lung abnormalities from changes caused by position or incomplete inspiration.

HRCT Chest is not the same as CECT Chest, CT pulmonary angiography or low-dose lung-cancer screening CT. A contrast-enhanced CT may be more appropriate for evaluating mediastinal masses, lymph nodes, blood vessels or certain infections and tumours. CT pulmonary angiography is specifically designed to examine the pulmonary arteries, while lung-cancer screening follows a dedicated low-dose protocol for eligible high-risk individuals.

Benefits of the Test

• Produces highly detailed thin-section images of the lung parenchyma.
• Helps detect subtle interstitial abnormalities that may be unclear on a chest X-ray.
• Assesses the pattern and distribution of pulmonary fibrosis and other diffuse lung diseases.
• Provides detailed evaluation of bronchiectasis and selected small-airway abnormalities.
• May help assess emphysema, cystic lung disease and occupational lung disorders.
• Can include expiratory views to identify air trapping when clinically indicated.
• Can include prone images to distinguish dependent changes from persistent disease.
• Supports multidisciplinary diagnosis, treatment planning and follow-up.
• Is fast, non-invasive and usually does not require intravenous contrast.
• Allows images to be reviewed in axial, coronal and sagittal planes.

Why Doctors Recommend This Test

Doctors may recommend HRCT Chest when a patient has persistent shortness of breath, chronic cough, reduced exercise tolerance or abnormal lung sounds and the cause remains uncertain after initial evaluation. The scan may be particularly useful when a chest X-ray is normal or inconclusive but clinical suspicion of diffuse lung disease remains high.

One of the primary uses of HRCT is the assessment of interstitial lung disease. Interstitial lung diseases include a large and varied group of conditions that affect the supporting tissues of the lungs. HRCT can demonstrate patterns such as ground-glass opacity, reticulation, traction bronchiectasis, honeycombing, nodules, cysts and areas of consolidation. The distribution of these findings can help narrow the possible diagnosis.

HRCT is commonly used to evaluate suspected pulmonary fibrosis. Fibrosis refers to scarring and structural distortion of lung tissue. The examination can help show the extent and distribution of fibrosis and identify features that may support a particular diagnostic pattern. Imaging findings are interpreted together with symptoms, exposure history, blood tests, pulmonary-function tests and sometimes biopsy results.

The scan may also be recommended for bronchiectasis, a condition in which the airways become permanently widened or distorted. HRCT can show the location and severity of bronchial dilatation, airway-wall thickening, mucus plugging and associated lung changes. These findings may help guide treatment and investigation of the underlying cause.

Doctors may request HRCT for suspected occupational or environmental lung disease. Relevant exposures may include dust, fumes, mould, asbestos, silica, coal dust, birds or certain workplace chemicals. A detailed exposure history is important because similar imaging patterns may arise from different causes.

HRCT may help evaluate emphysema and selected small-airway diseases. Expiratory images can demonstrate air trapping, which occurs when parts of the lung do not empty normally during exhalation. However, HRCT findings must be correlated with spirometry or other pulmonary-function tests because imaging and lung function provide different information.

The examination may also be used for follow-up of a known lung condition, assessment of treatment response or investigation of worsening symptoms. Repeated imaging should be performed only when medically justified because CT uses ionizing radiation.

Preparation Before Test

Most HRCT Chest examinations require little preparation because intravenous contrast is usually not administered. Patients can generally eat, drink and take regular medicines normally unless Focus Diagnostics or the referring doctor provides different instructions.

Wear loose, comfortable clothing without metal around the chest. Necklaces, jewellery, underwire garments, removable metallic accessories and other objects that may interfere with the images should be removed. Patients may be asked to change into a gown.

Bring the doctor's prescription and relevant clinical information. Previous chest X-rays, CT scans, HRCT images, pulmonary-function test reports, laboratory results, biopsy records and treatment details should also be provided. Comparison with earlier examinations can help the radiologist assess whether abnormalities are new, stable, improving or progressing.

Inform the imaging team about current respiratory symptoms, oxygen use, recent infection, previous chest surgery, known lung disease and occupational or environmental exposure. This information can help the radiologist interpret the pattern and distribution of abnormalities more accurately.

Women who are pregnant or may be pregnant must inform the referring doctor and CT team before the examination. The healthcare professionals can assess the urgency, expected benefit, radiation exposure and whether another approach is suitable. Children and younger patients require protocols adjusted to body size and clinical need.

During the scan, the patient usually lies on the back with the arms placed above the head when physically possible. Clear breathing instructions are essential. The technologist may ask the patient to take a deep breath and hold it for several seconds while images are captured.

If expiratory images are required, the patient will be asked to breathe out and hold the breath. Prone images may require lying on the stomach for a short time. Patients who cannot lie flat, raise their arms or follow breathing instructions should tell the technologist so the examination can be adapted where possible.

Normal Reporting Time

The actual HRCT image acquisition usually takes only a few minutes. Registration, clinical review, positioning, practice of breathing instructions and reconstruction of thin-section images increase the total appointment time. Additional prone or expiratory views may require more time.

Many routine HRCT Chest reports may be available within 24 to 48 hours. Complex interstitial lung disease, comparison with multiple previous examinations or cases requiring specialist thoracic-radiology review may take longer. Urgent findings are prioritized according to clinical requirements and the centre's procedures.

Scan duration and reporting time are different. Although the images are acquired quickly, the radiologist must examine both lungs systematically and assess the type, distribution and extent of any abnormalities. Fine details may need to be reviewed at multiple window settings and in several anatomical planes.

The report may describe abnormalities using technical terms such as ground-glass opacity, reticulation, honeycombing, traction bronchiectasis, mosaic attenuation or air trapping. The referring doctor or pulmonologist should explain these findings in relation to the patient's symptoms and other investigations.

Who Should Take This Test?

HRCT Chest may be appropriate for patients with suspected interstitial lung disease, pulmonary fibrosis, bronchiectasis, emphysema, small-airway disease, cystic lung disease or occupational lung disease. It may also be recommended when respiratory symptoms persist despite an inconclusive chest X-ray.

Patients with chronic cough, unexplained shortness of breath, reduced oxygen levels or abnormal pulmonary-function tests may undergo HRCT when recommended by a pulmonologist or another qualified healthcare professional. These symptoms have many possible causes, and HRCT is only one part of the diagnostic evaluation.

The examination may be used for selected patients with autoimmune conditions that can affect the lungs, such as systemic sclerosis or rheumatoid arthritis. It may also be recommended for people taking medicines associated with potential lung toxicity, when clinical assessment suggests pulmonary involvement.

People with significant occupational or environmental exposure and respiratory symptoms may require HRCT to assess possible lung damage. The type, duration and intensity of exposure should be communicated to the treating doctor and radiologist.

HRCT Chest is not intended as a general health screening test for everyone. It does not replace a dedicated low-dose lung-cancer screening program, CT pulmonary angiography, CECT Chest or routine clinical examination. The appropriate scan should be selected according to the specific clinical indication.

Severe breathing difficulty, sudden chest pain, bluish discoloration, coughing up a significant amount of blood, confusion or rapidly falling oxygen levels require urgent medical assessment. Patients should not wait for a routine HRCT appointment in an emergency.

Detailed Information

The lungs contain millions of tiny air sacs called alveoli, supported by a fine interstitial framework. This framework includes tissues around the air sacs, small blood vessels and airways. Interstitial diseases can cause inflammation, fluid accumulation, cellular infiltration or fibrosis within this supporting tissue.

HRCT uses very thin image sections and a high-spatial-frequency reconstruction algorithm to demonstrate fine lung detail. Modern scanners may acquire the entire chest volumetrically, allowing the radiologist to scroll through contiguous images and create high-quality multiplanar views.

Inspiratory images are usually the main component of the examination. A full breath helps expand the lungs and reduces misleading changes caused by low lung volume. Inadequate inspiration can make normal dependent lung tissue appear abnormally dense, so cooperation with breathing instructions is important.

Expiratory images may be obtained when small-airway obstruction or air trapping is suspected. During normal exhalation, lung density increases relatively evenly. Areas that remain unusually dark may indicate trapped air, although interpretation depends on image quality and clinical context.

Prone images may be used when abnormalities are seen in the back portions of the lungs on supine images. Dependent lung density caused by gravity may disappear when the patient lies prone, while true interstitial disease generally persists. Prone imaging is added only when it may answer a specific diagnostic question.

Ground-glass opacity describes increased lung density that does not completely obscure underlying blood vessels. It is a non-specific finding that may occur with inflammation, infection, fluid, partial air-space filling or early fibrosis. The pattern, distribution, clinical history and associated findings determine its significance.

Reticulation refers to a network of fine lines within the lungs. Traction bronchiectasis occurs when fibrotic tissue pulls the airways open. Honeycombing describes clustered cystic air spaces, usually near the outer lung surface, and may indicate established fibrosis in the appropriate clinical context.

Mosaic attenuation describes patchwork differences in lung density. It may be associated with small-airway disease, vascular abnormalities or uneven lung involvement. Expiratory imaging and clinical correlation can help determine the likely cause.

Bronchiectasis is assessed by examining airway diameter, wall thickness, tapering and visibility toward the lung periphery. Mucus plugging, small nodules and tree-in-bud patterns may provide additional information about airway infection or inflammation.

HRCT can strongly suggest certain patterns of diffuse lung disease, but not every case has a single specific appearance. Diagnosis may require multidisciplinary discussion among pulmonologists, radiologists, pathologists and other specialists. Blood tests, exposure assessment, bronchoscopy or lung biopsy may occasionally be necessary.

HRCT uses ionizing radiation. The dose depends on patient size, scan coverage, number of phases and imaging technique. Additional expiratory or prone acquisitions add exposure, so they are performed only when clinically useful. The diagnostic team selects parameters intended to provide adequate image quality while limiting unnecessary radiation.

After a routine non-contrast HRCT, patients can generally resume normal activities immediately. No injected contrast needs to be cleared from the body. The final report should be reviewed by the referring doctor or pulmonologist, who will correlate the imaging pattern with symptoms, lung-function measurements, laboratory tests and medical history before recommending treatment or further investigation.